BiotechTube
Home/Endevica Bio/Daniel Marks
DM

Daniel Marks

Chief Scientific and Medical Officer

Endevica Bio

Therapeutic Areas

Metabolic DisordersObesityCancer Cachexia

Endevica Bio Pipeline

DrugIndicationPhase
710GOGeneral ObesityPhase 1
Mifomelatide (TCMCB07)Cancer CachexiaPhase 2

Leadership Team at Endevica Bio

RP
Russell Potterfield
Chief Executive Officer
View full Endevica Bio profile